Effect of immune mechanisms on the pharmacokinetics and organ distribution of Cryptococcal polysaccharide

Journal of Infectious Diseases

Volumn 177, Issue 6, 1998, Pages 1647-1659

  Lendvai, Nikoletta ^c   Casadevall, Arturo ^a   Liang, Zhenglu ^c   Goldman, David L ^c   Mukherjee, Jean ^b   Zuckier, Lionel ^c  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; COMPLEMENT; CYANOGEN BROMIDE; FC RECEPTOR; IMMUNOGLOBULIN M; MANNAN; MONOCLONAL ANTIBODY; POLYSACCHARIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN ANTIBODY COMPLEX; ARTICLE; COMPLEMENT DEPOSITION; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; ORGAN DISTRIBUTION; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

EID: 0031748919     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/515329     Document Type: Article

References (14)

1. Musher DM. Streptococcus pneumoniae. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. New York: Churchill Livingstone, 1995:1811-26.
2. Moxon ER. Haemophilus influenzae. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. New York: Churchill Livingstone, 1995:2039-45.
3. Lee SC, Casadevall A. Polysaccharide antigen in brain tissue of AIDS patients with cryptococcal meningitis. Clin Infect Dis 1996;23:194-5.
4. Pirofski L, Casadevall A. Cryptococcus neoformans: paradigm for the role of antibody immunity against fungi? Zentralbl Bakteriol 1996;284:475-95.
5. Cherniak R, Sundstrom JB. Polysaccharide antigens of the capsule of Cryptococcus neoformans. Infect Immun 1994;62:1507-12.
6. Dong ZM, Murphy JW. Intravascular cryptococcal culture filtrate (CneF) and its major component, glucuronoxylomannan, are potent inhibitors of leukocyte accumulation. Infect Immun 1995;63:770-8.
7. Drouhet E, Segretain G. Inhibition de la migration leucocytaire in vitro par un polyoside capsulaire de Torulopsis (Cryptococcus) neoformans. Ann Inst Pasteur 1951;81:674.
8. Dong ZM, Murphy JW. Cryptococcal polysaccharides induce L-selectin shedding and tumor necrosis factor receptor loss from the surface of human neutrophils. J Clin Invest 1996;97:689-98.
9. Kozel TR, Gulley WF, Cazin J Jr. Immune response to Cryptococcus neoformans soluble polysaccharide: immunological unresponsiveness. Infect Immun 1977;18:701-7.
10. Murphy JW, Cozad GC. Immunological unresponsiveness induced by cryptococcal polysaccharide assayed by the hemolytic plaque technique, Infect Immun 1972;5:896-901.
11. Sundstrom JB, Cherniak R. T-cell dependent and T-cell-independent mechanisms of tolerance to glucuronoxylomannan of Cryptococcus neoformans serotype A. Infect Immun 1993;61:1340-5.
12. Hirano A, Zimmerman HM, Levine S. Fine structure of cerebral fluid accumulation. VI. Intracellular accumulation of fluid and cryptococcal polysaccharide in oligodendria. Arch Neurol 1965;12:189-96.
13. Kozel TR, Gotschlich E. The capsule of Cryptococcus neoformans passively inhibits phagocytosis of the yeast by macrophages. J Immunol 1982;129:1675-80.
14. Retini C, Vecchiarelli A, Monari C, Tascini C, Bistoni F, Kozel TR. Capsular polysaccharide of Cryptococcus neoformans induces proinflammatory cytokine release by human neutrophils. Infect Immun 1996;64:2897-903.